Butala Emporium, Inc. Recalls Eleven Ayurvedic Dietary Supplements Because of Elevated Levels of Lead and Mercury

Similar documents
Detox Transforms Health and Nutrition Issues Voluntary Nationwide Recall of Dietary Supplements Due to the Presence of Undeclared Drug Ingredients

Recall -- Firm Press Release

Company Announcement. For Immediate Release. Contact. Announcement

2 Mylan Valsartan/Combination Class 2 Recall

Product NDC Code Lot Number Expiry Dates Distribution Date VALSARTAN TABLETS 40MG 30CT

Home Food Resources for You Consumers. Food

Contacts Consumers:

FOR IMMEDIATE RELEASE

Inspections, Compliance, Enforcement, and Criminal Investigations

POLICY AND PROCEDURE DOCUMENT NAME: Drug Recall Notification Process

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations

Hospira Issues A Voluntary Nationwide Recall For 8.4% Sodium Bicarbonate Injection, USP,

US FDA/CDRH: Public Health Notification: Serious Complications Associated with Transvaginal Place... FDA Home Page CDRH Home Page Search A-Z Index

TreeHouse Foods Amends Best By Dates in Voluntary Product Recall of Macaroni & Cheese Cup Products

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations

BAXTER INITIATES VOLUNTARY NATIONWIDE RECALL OF SELECT LOTS OF IV SOLUTIONS DUE TO THE POTENTIAL FOR LEAKING CONTAINERS AND PARTICULATE MATTER

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

Magnesium Sulfate in Water for Injection is indicated for the prevention and control of seizures in preeclampsia and eclampsia, respectively.

4/26/2013. Libia Lugo Drug Specialist San Juan District Office Investigations Branch

Inspections, Compliance, Enforcement, and Criminal Investigations

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube

Please see the attached drug alert for onward transmission as below.

Agency Information Collection Activities; Submission for Office of Management and Budget

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

Suspected Defective Product Report

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

LIVE INTERACTIVE YOUR DESKTOP. Food Recall Process. Cecilia M. Wolyniak Food and Drug Administration Office of Enforcement

Opportunities for Building Awareness and Urgency. Presenter: Adam Ismail

American Emu Association. Certified Emu Oil Program

IMPORTANT DRUG INFORMATION

PATIENT INFORMATION LEAFLET

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

AFDO Conference June 9, Mercedes Mota, Director Medical Device, Surgical Care Johnson & Johnson Quality & Compliance Worldwide

URGENT: Important Safety Information

Newfoundland & Labrador BEVERAGE DISTRIBUTOR GUIDE

Recall Guidelines. for Chinese Medicine Products

Food Recalls: May 25, 2016 GREENBERG TRAURIG, LLP ATTORNEYS AT LAW Greenberg Traurig, LLP. All rights reserved.

The Role of USDA s Food Safety and Inspection Service to Ensure Foodborne Disease Control and Prevention

DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.

Introducing The USDA Food and Nutrient Database for Dietary Studies

Read all of this leaflet carefully before you start taking this medicine

Healthy Opportunity. Hi5 Line of Wellness Products

Package leaflet: Information for the user Cyklokapron 500 mg Solution for Injection tranexamic acid

October 12-14, 2017 Miami, Florida, USA University of Miami, Miami, USA

OVERVIEW. Prerequisites

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Patient-Focused Drug Development Public Meeting on Chagas Disease

Supporting our provider partners through communication and collaboration. Formulary Updates

GUIDELINES FOR REGISTRATION OF NUTRITIONAL SUPPLEMENTS FINAL DRAFT

Proposition 65 and Supplements

Over-the-Counter Pediatric Liquid Drug Products Containing Acetaminophen

Taking the Mystery Out of TEFAP. Rosie Krueger Child Nutrition Programs Vermont Agency of Education. Diversity & Inclusion

PHENYTOIN SODIUM National Drug Code Directory

Consumer Medicine Information TOPICIL. Please read this leaflet carefully before you start using Topicil Capsules.

Effexor XR 150mg and one lot of Greenstone Venlafaxine 150mg extended-release capsules

National Drug Code Directory

Package Leaflet: Information for the User

SUMMARY: The Food and Drug Administration (FDA) is requesting public input on updated

DATES: This rule is effective December 8, See section X for further information on the

If you need the information on this leaflet in an alternative format, such as large text, or Braille please ring from the UK:

Module Bi. Health Hazards of Lead

IN THE UNITED STATES DISTRICT COURT FOR THE EASTERN DISTRICT OF PENNSYLVANIA

CLINICAL MANIFESTATIONS ASSESSMENT OF RESPIRATORY DISEASE 6TH EDITION

Experimental Biology 2017

NovoPen Echo URGENT MEDICAL DEVICE RECALL

Three-Month Extension of Certain Tobacco Product Compliance Deadlines Related to the

Highly Concentrated Caffeine in Dietary Supplements; Guidance for Industry; Availability

Mydrilate eye drops are applied on the surface of the eyes for diagnostic purposes during eye examinations and refraction tests.

SUMMARY: The Food and Drug Administration (FDA or we) is amending the color additive

PACKAGE LEAFLET. Page 1 of 6

SPONSORSHIP OPPORTUNITIES

FDA Approves Novartis Single-pill Combination Drug Tekamlo To Treat High Blood Pressure.: An Article From: Transplant News [HTML] [Digital] By

NewcastleX COURSE OUTLINE THE SCIENCE OF WEIGHT LOSS: DISPELLING DIET MYTHS OVERVIEW COURSE DESCRIPTION PREREQUISITES TIME COMMITMENT

PATIENT INFORMATION LEAFLET: Lancap 15 mg and 30 mg. Please read this leaflet carefully before taking LANCAP capsules.

Department of Origin: Integrated Healthcare Services. Approved by: Chief Medical Officer Department(s) Affected: Date approved: 01/10/17

PATIENT INFORMATION LEAFLET Cyclophosphamide 50 mg Tablets Cyclophosphamide monohydrate

13961/12 SB/ak 1 DG B II

Aluminum in Vaccines:

Guidelines for the Recall or Withdrawal of a Medical Product

Home Health Aide Training. Worksheets for Section 2

COLLOIDAL SILVER. Compiled by. Campbell M Gold (2009) CMG Archives --()-- IMPORTANT

PATIENT INFORMATION LEAFLET

Lesson 1 - Introduction to Pharmacology Assignments

Guidelines for Product Recall or Withdrawal

AKA Good Manufacturing Practice (GMP) Certification Program

B. PACKAGE LEAFLET. Page 1 of 6

DAEHSAN BIOTECH PRIVATE LIMITED Industrial Growth Centre, Assam Industrial Development Corporation, Balipara, Sonitpur, Assam.

George Misko is a Partner at Keller and Heckman LLP George joined Keller and Heckman in Mr. Misko's practice focuses on food and drug matters

Memantine pronounced as (mem' an teen)

Guidance for Industry

Day Valerian Root Extract Hops Extract. Read all of this leaflet carefully because it contains important information for you.

Opiate Freedom Center 1/11/18

Prescriber and Pharmacy Guide for the Tracleer REMS Program

Transcription:

Recalls, Market Withdrawals, & Safety Alerts > Butala Emporium, Inc. Recalls Eleven Ayurvedic Dietary Supplements Because of Elevated Levels of Lead and Me... U.S. Food and Drug Administration back to Recalls, Market Withdrawals, & Safety Alerts Recall -- Firm Press Release FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company. Butala Emporium, Inc. Recalls Eleven Ayurvedic Dietary Supplements Because of Elevated Levels of Lead and Mercury Contact: Consumer: Shaswat Butala 718-899-5590 FOR IMMEDIATE RELEASE September 15, 2015 Jackson Heights, NY Butala Emporium, Inc of Jackson Heights, NY, is voluntarily recalling eleven Ayurvedic (dietary) supplements (listed below) because the products were found to contain elevated lead and mercury levels which may cause health problems to consumers, particularly infants, small children, pregnant women, and those with underlying kidney disorders if consumed.the concentration of lead exceeds the recommended daily lead exposure for children less than 6 years of age and women of childbearing age and would likely be injurious to health. If a child or a pregnant woman is exposed to lead for a protracted period of time (e.g., weeks to months) permanent damage to the central nervous system, learning disorders, developmental defects, and other long-term health problems can occur. The problems that might occur are dependent on the duration and degree of exposure. The mercury levels in these products are high and exceed the weekly intake exposure and would likely be http://www.fda.gov/safety/recalls/ucm463048.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery[9/18/2015 6:43:32 AM]

Recalls, Market Withdrawals, & Safety Alerts > Butala Emporium, Inc. Recalls Eleven Ayurvedic Dietary Supplements Because of Elevated Levels of Lead and Me... injurious to health. The elevated mercury levels in these products with short term use can cause kidney, stomach and intestinal (or gut) symptoms, while month-long use of these products could be potentially lethal. Mercury consumption at these levels can also cause psychiatric and personality disturbances, ataxia (or loss of coordination), visual loss, hearing loss, and other neurological conditions particularly exposed in utero. Butala is notifying individuals not to consume this product. Baidyanath brand Saptamrit Lauh--Batch No. SPL-04, Expiry Date 4/2018 Baidyanath brand Rajahpravartini Bati--Batch No. RAJ-15 0 & 126, Expiry Date 1/2019 & 07/2016 Baidyanath brand Sarivadi Bati--Batch No. SRI-09, Expiry Date 04/2018 Baidyanath brand Shankh Bati--Batch No. SHN-02, Expiry Date 08/2018 Baidyanath brand Marichyadi Bati--Batch No. 200, Expiry Date 08/2017 Baidyanath brand Agnitundi Bati--Batch No. 018, Expiry Date 02/2016 Baidyanath brand Arogyavardhini Bati--Batch No. 018, Expiry Date 03/2017 Baidyanath brand Sarivadi Bati--Batch No. SARI-015, Expiry Date 01/2019 Baidyanath brand Brahmi Bati--Batch No. HGB-18, Expiry Date 03/2019, Batch Nos. 244 & 242, Expiry Date 03/2017 (products without Batch No. or Expiry Date are subject to this recall) Baidyanath brand Gaisantak Bati--Batch No. GAI-09, Expiry Date 08/2018 and Batch No. 141, Expiry Date 10/2017 Baidyanath brand Chitrakadi Bati--Batch No. 193, Expiry Date 02/2018 The 80-count-capsules are packed in white, plastic bottles with green, yellow or orange labeling under the brand name Baidyanath made by Shree Baidyanath Ayurved Bhawan (P) Ltd. 1 Gupta Lane, Kolkata, India and top cap sticker with imported by Butala Emporium The product was distributed in NY through retail stores and to consumers as single unit purchases via the firms internet site within CA, CT, FL, HI, MA, NJ, OH, PA, VT, D.C. and PR). No complaints or illnesses have been received to date. The recall was initiated after it was discovered that the products contain high levels of lead and mercury based on NYC Department of Health laboratory and U.S. Food and Drug Administrating testing. Pregnant women and patients with underlying kidney problems who may have consumed any of the above products should consult with their physician or health care provider. For more information, consumers should contact their local poisoning prevention program or local public health department. Consumers who have purchased these products are urged not to consume the product and should return them to the place of purchase for a full refund. Consumers with questions may contact the company at 1-718-899-5590, Monday Friday, 9 am 5 pm ET or email butala1@aol.com. Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax. Complete and submit the report Online: www.fda.gov/medwatch/report.htm Regular Mail or Fax: Download form www.fda.gov/medwatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit http://www.fda.gov/safety/recalls/ucm463048.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery[9/18/2015 6:43:32 AM]

Recalls, Market Withdrawals, & Safety Alerts > Butala Emporium, Inc. Recalls Eleven Ayurvedic Dietary Supplements Because of Elevated Levels of Lead and Me... by fax to 1-800-FDA-0178 ### RSS Feed for FDA Recalls Information [what s this?] Photo: Product Labels Recalled Product Photos Are Also Available on FDA's Flickr Photostream. Page Last Updated: 09/17/2015 Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players. Accessibility FDA Basics No FEAR Act Transparency Careers FOIA Site Map Website Policies U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 1-888-INFO-FDA (1-888-463-6332) Contact FDA FDA Archive Combination Products http://www.fda.gov/safety/recalls/ucm463048.htm?source=govdelivery&utm_medium=email&utm_source=govdelivery[9/18/2015 6:43:32 AM]